Literature DB >> 33038416

NPD1 rapidly targets mitochondria-mediated apoptosis after acute injection protecting brain against ischemic injury.

Hylde Zirpoli1, Sergey A Sosunov2, Zoya V Niatsetskaya2, Korapat Mayurasakorn1, Denny Joseph Manual Kollareth1, Charles N Serhan3, Vadim S Ten4, Richard J Deckelbaum5.   

Abstract

Mitochondria-related cell death pathways play a major role in ischemic brain injury. Thus, mitochondrial "protective" molecules could be considered for new therapeutic regimens. We recently reported that acute administration of docosahexaenoic acid (DHA) triglyceride lipid emulsion, immediately after hypoxic-ischemic (HI) insult, markedly attenuated brain infarct size. This was associated with an early change of DHA-derived specialized pro-resolving mediator (SPM) profiles. Specifically, DHA treatment induced a 50% increase of neuroprotectin D1 (NPD1) levels in ischemic brain. Based on these findings, we questioned if direct administration of NPD1 after HI injury also affords neuroprotection, and if so, by what mechanisms. Using HI insult to mimic ischemic stroke in neonatal mice, we observed that acute intraperitoneal injection of NPD1 immediately after HI injury prevented the expansion of the ischemic core by ~40% and improved coordination and motor abilities compared to the control group. At 7 days after HI injury, NPD1 treatment decreased ipsilateral hemisphere atrophy and preserved motor functions in wire-holding and bridge-crossing tests compared to control littermates. Brain mitochondria, isolated at 4 h after reperfusion from mice treated with NPD1, showed an increase in the capacity to buffer calcium after HI injury, as result of the preservation of mitochondrial membranes. Further, NPD1 induced a reduction of mitochondrial BAX translocation and oligomerization, attenuated cytochrome C release and decreased AIF nuclear translocation. To confirm whether NPD1 acts as BAX inhibitor, we evaluated NPD1 action co-administrated with a pro-apoptotic agent, staurosporine, using mouse embryonic fibroblasts as in vitro model of apoptosis. NPD1 exposure markedly decreased mitochondria-mediated apoptosis, blocking BAX translocation from cytosol to mitochondria and subsequently reducing caspase-3 activation. Our findings provide novel evidence that the neuroprotective action of NPD1 is elicited rapidly in the first few hours after ischemic injury and is associated with both preserved mitochondrial membrane structure and reduced BAX mitochondrial translocation and activation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; BAX; DHA; Ischemic brain injury; Mitochondria; NPD1

Mesh:

Substances:

Year:  2020        PMID: 33038416     DOI: 10.1016/j.expneurol.2020.113495

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  5 in total

1.  Acute Injection of Omega-3 Triglyceride Emulsion Provides Very Similar Protection as Hypothermia in a Neonatal Mouse Model of Hypoxic-Ischemic Brain Injury.

Authors:  Denny Joseph Manual Kollareth; Hylde Zirpoli; Vadim S Ten; Richard J Deckelbaum
Journal:  Front Neurol       Date:  2021-01-15       Impact factor: 4.003

2.  Docosahexaenoic acid supplementation represses the early immune response against murine cytomegalovirus but enhances NK cell effector function.

Authors:  Shuting Wu; Lili Wang; Shanshan Wang; Hongyan Peng; Shuju Zhang; Qinglan Yang; Minghui Huang; Yana Li; Shuzhen Guan; Wenjuan Jiang; Zhaohui Zhang; Qinghua Bi; Liping Li; Yuan Gao; Peiwen Xiong; Zhaoyang Zhong; Bo Xu; Yafei Deng; Youcai Deng
Journal:  BMC Immunol       Date:  2022-04-19       Impact factor: 3.594

3.  Norepinephrine Inhibits Lipopolysaccharide-Stimulated TNF-α but Not Oxylipin Induction in n-3/n-6 PUFA-Enriched Cultures of Circumventricular Organs.

Authors:  Fabian Johannes Pflieger; Jacqueline Wolf; Martin Feldotto; Andreas Nockher; Tatjana Wenderoth; Jessica Hernandez; Joachim Roth; Daniela Ott; Christoph Rummel
Journal:  Int J Mol Sci       Date:  2022-08-06       Impact factor: 6.208

Review 4.  Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.

Authors:  Mariarosaria Valente; Marta Dentoni; Fabrizio Bellizzi; Fedra Kuris; Gian Luigi Gigli
Journal:  Molecules       Date:  2022-07-28       Impact factor: 4.927

5.  Docosahexaenoic Acid Alleviates Brain Damage by Promoting Mitophagy in Mice with Ischaemic Stroke.

Authors:  Eryi Sun; Jing Zhang; Yan Deng; Jun Wang; Qi Wu; Wei Chen; Xiaodong Ma; Siyuan Chen; Xin Xiang; Yujie Chen; Tairong Wu; Yang Yang; Bo Chen
Journal:  Oxid Med Cell Longev       Date:  2022-10-08       Impact factor: 7.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.